The Pharmacy Times® Pharmacy Technician Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to specialty pharmacists.
May 2nd 2025
New trial results highlight intravenous immunoglobulin (IVIG) 10% as an effective rescue treatment for relapsing chronic inflammatory demyelinating polyradiculoneuropathy (CIDP), enhancing patient care and pharmacist involvement in management.
AAO-HNSF Publishes Clinical Practice Guidelines for Allergen Immunotherapy
March 4th 2024AAO-HNSF guideline development group included 17 panel members, including experts from otolaryngology and allergy, those who have knowledge in clinical practice guideline development, and patient representatives.
Read More
Pharmacy’s Role in Treating Rare Disease: Connecting Patients, Providers, Payers, and Pharma
February 29th 2024Pharmacy's position at the intersection of the care team gives it a unique ability to connect providers, payers, and pharmaceutical manufacturers, and support patients to maximize their health outcomes.
Read More
Expert Discusses Quality Standards' Role in the Evolution of Biosimilars and Biologics Landscape
February 13th 2024Fouad Atouf, senior vice president of global biologics at US Pharmacopeia, discusses how established quality standards, drawing from the realm of small molecule drugs and evolving to meet the complexities of biologics, play a pivotal role in fostering trust.
Watch
USP Expert Discusses Concerns on Biosimilar Safety and Efficacy Through Quality Standards
February 12th 2024Fouad Atouf, senior vice president of global biologics at US Pharmacopeia, discusses the importance of robust quality standards in addressing concerns regarding biosimilar safety and efficacy.
Watch
Recurrent C difficile Infection Prevention: Efficacy and Administration of Fecal Microbiota Therapy
January 31st 2024Sharon Rimon, NP, shares insights on the rectal administration of fecal microbiota therapy, highlighting its efficacy, ease of adoption in clinical practice, and benefits for patients.
Read More
Guideline Update: KDIGO 2024 Management of Lupus Nephritis Includes Belimumab for Triple Therapy
January 11th 2024The update includes a recommended triple therapy with belimumab as a first line treatment for class III or IV lupus nephritis following the approvals of belimumab and voclosporin.
Read More